Male Urinary / Prostate Review (IPSS)

If you have been advised by the surgery to complete a prostate questionnaire please use this form. This works out your International Prostate Symptom Score (IPSS).

Male Urinary / Prostate Review (IPSS)

Male Urinary / Prostate Review (IPSS)

About You

Please use this date format: DD/MM/YYYY.

In the past month:

How often have you had the sensation of not emptying your bladder? *
How often have you had to urinate less than every 2 hours? *
How often have you found you stopped and started again several times when you urinated? *
How often have you found it difficult to postpone urination? *
How often have you had a weak urinary stream? *
How often have you had to strain to start urination? *
How many times do you typically get up at night to urinate? *

Quality of Life due to urinary symptoms

About the I-PSS

The International Prostate Symptom Score (I-PSS) is based on the answers to seven questions concerning urinary symptoms and one question concerning quality of life. Each question concerning urinary symptoms allows the patient to choose one out of six answers indicating increasing severity of the particular symptom. The answers are assigned points from 0 to 5. The total score can therefore range from 0 to 35 (asymptomatic to very symptomatic).

The questions refer to the following urinary symptoms:

1. Incomplete emptying
2. Frequency
3. Intermittency
4. Urgency
5. Weak Stream
6. Straining
7. Nocturia

Question eight refers to the patient’s perceived quality of life.

The first seven questions of the I-PSS are identical to the questions appearing on the American Urological Association (AUA) Symptom Index which currently categorizes symptoms as follows:

- Mild (symptom score less than of equal to 7)
- Moderate (symptom score range 8-19)
- Severe (symptom score range 20-35)

The International Scientific Committee (SCI), under the patronage of the World Health Organization (WHO) and the International Union Against Cancer (UICC), recommends the use of only a single question to assess the quality of life. The answers to this question range from “delighted” to “terrible” or 0 to 6. Although this single question may or may not capture the global impact of benign prostatic hyperplasia (BPH) Symptoms or quality of life, it may serve as a valuable starting point for a doctor-patient conversation.

The SCI has agreed to use the symptom index for BPH, which has been developed by the AUA Measurement Committee, as the official worldwide symptoms assessment tool for patients suffering from prostatism.

The SCI recommends that physicians consider the following components for a basic diagnostic workup: history; physical exam; appropriate labs, such as U/A, creatine, etc.; and DRE or other evaluation to rule out prostate cancer.